CAPSTONE THERAPEUTICS CORP.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1987-01-01
- Employees
- 47
- Market Cap
- -
- Website
- http://www.capstonethx.com
Clinical Trials
4
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
A Study to Evaluate the Safety and Efficacy of Additional Doses of AZX100 Drug Product Following Excision of Keloid Scars
- Conditions
- Scar PreventionScar Reduction
- Interventions
- Drug: AZX100 Drug ProductDrug: Placebo
- First Posted Date
- 2009-05-04
- Last Posted Date
- 2012-10-11
- Lead Sponsor
- Capstone Therapeutics
- Target Recruit Count
- 59
- Registration Number
- NCT00892723
- Locations
- 🇺🇸
Lotus Clinical Research, Inc., Pasadena, California, United States
🇺🇸Paddington Testing Company, Inc., Philadelphia, Pennsylvania, United States
🇺🇸DermResearch, Inc., Austin, Texas, United States
A Study to Evaluate the Safety and Efficacy of AZX100 Drug Product Following Excision of Keloid Scars
- Conditions
- Scar PreventionScar Reduction
- Interventions
- Drug: AZX100 Drug ProductDrug: Placebo
- First Posted Date
- 2009-01-21
- Last Posted Date
- 2012-10-11
- Lead Sponsor
- Capstone Therapeutics
- Target Recruit Count
- 59
- Registration Number
- NCT00825916
- Locations
- 🇺🇸
Paddington Testing Company, Inc., Philadelphia, Pennsylvania, United States
🇺🇸DermResearch, Inc., Austin, Texas, United States
A Phase 2a Study to Evaluate the Safety and Efficacy of AZX100 in Trocar Sites of Arthroscopic Shoulder Surgery Patients
- First Posted Date
- 2008-12-19
- Last Posted Date
- 2012-10-11
- Lead Sponsor
- Capstone Therapeutics
- Target Recruit Count
- 150
- Registration Number
- NCT00811577
- Locations
- 🇺🇸
Lotus Clinical Research, Inc., Pasadena, California, United States
🇺🇸Florida Research Associates, Deland, Florida, United States
🇺🇸Atlas Orthopedics & Sports Medicine, Orlando, Florida, United States
A Study to Evaluate the Safety and Effectiveness of Different Doses of Chrysalin in Adults Who Have a Broken Wrist
- First Posted Date
- 2005-08-18
- Last Posted Date
- 2010-08-24
- Lead Sponsor
- Capstone Therapeutics
- Target Recruit Count
- 274
- Registration Number
- NCT00131482
- Locations
- 🇺🇸
OrthoLogic, Tempe, Arizona, United States